Form 4: Biodesix CFO Robin Harper Cowie Reports Stock Transactions

Robin Harper Cowie, CFO, Secretary, and Treasurer of Biodesix Inc., reports the acquisition and disposal of common stock and restricted stock units.

Summary

• On May 8, 2024, Robin Harper Cowie acquired 3,157 shares of common stock through the vesting of restricted stock units (RSUs).
• On May 9, 2024, Cowie disposed of 980 shares of common stock at a price of $1.4795 per share.
• Following these transactions, Cowie beneficially owns 171,680 shares of common stock and 22,097 restricted stock units.
• The sale of shares was to cover taxes upon the vesting of RSUs.
• The RSUs vest in sixteen successive quarterly installments from February 8, 2022.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates activity by a key executive at Biodesix, providing investors with insights into their stock ownership.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• Comparable companies like Exact Sciences (EXAS) and Guardant Health (GH) also have similar filings when their executives trade company stock.
• The volume of shares traded and the price per share are typical for transactions related to RSU vesting and tax obligations.

Stakeholder Impact

• Shareholders may be interested in the trading activity of company insiders as an indicator of management's confidence in the company.
• The transactions are related to RSU vesting, which is part of the compensation package for employees and executives.

Key Dates